| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 56.356 | 53.104 | 39.842 | 56.471 | 84.810 | 72.685 | 55.627 | 99.789 | 99.549 | 77.694 |
| Total Income - EUR | 56.357 | 53.105 | 39.842 | 56.472 | 85.066 | 74.755 | 55.628 | 99.812 | 99.552 | 77.700 |
| Total Expenses - EUR | 51.369 | 42.395 | 59.492 | 54.683 | 61.721 | 43.604 | 30.358 | 66.907 | 56.045 | 195.440 |
| Gross Profit/Loss - EUR | 4.988 | 10.710 | -19.650 | 1.789 | 23.345 | 31.150 | 25.270 | 32.905 | 43.507 | -117.740 |
| Net Profit/Loss - EUR | 3.286 | 10.176 | -20.199 | 1.213 | 22.496 | 30.423 | 24.712 | 31.902 | 42.509 | -120.118 |
| Employees | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Adessa Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 315 | 247 | 957 | 572 | 104.295 | 96.977 | 89.796 | 85.957 | 80.427 | 119.542 |
| Current Assets | 43.599 | 48.971 | 30.356 | 30.924 | 48.053 | 75.273 | 111.063 | 95.732 | 154.743 | 40.611 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 41.957 | 38.895 | 24.612 | 25.714 | 38.380 | 61.110 | 79.513 | 84.962 | 84.597 | 26.908 |
| Cash | 1.641 | 10.076 | 5.745 | 5.210 | 9.673 | 14.163 | 31.550 | 10.770 | 70.146 | 13.703 |
| Shareholders Funds | 37.831 | 47.622 | 26.616 | 27.341 | 49.308 | 78.796 | 101.761 | 133.978 | 176.081 | 54.979 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 6.082 | 1.596 | 4.697 | 4.155 | 103.041 | 93.454 | 99.098 | 47.711 | 59.090 | 105.174 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Adessa Med Srl